| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
* From the Department of Anesthesiology, Kangnam Saint Mary's Hospital, 505 Banpo-dong, Seocho-gu, Seoul, Korea. 137-040, and Puget Sound Veterans Affairs Medical Center
and the University of Washington School of Medicine, Seattle, Washington.
Address correspondence to: Dr. Jong H. Choi; Phone: 82-2-590-1545; Fax: 82-2-537-1951; E-mail: jchoi{at}cmc.cuk.ac.kr
| Abstract |
|---|
|
|
|---|
Methods: Forty-three patients having combined thoracic epidural and general anesthesia for subtotal gastrectomy were randomly assigned to one of two study groups. All received a bolus dose of 3 mg epidural morphine at the beginning of surgery, followed by a continuous epidural infusion containing 3 mg morphine in 100 ml bupivacaine 0.125% with either no naloxone (control group, n=18) or a calculated dose of 0.208 µgkg1hr1 of naloxone (experimental group, n=25) for 48 hr. We measured the time to the first postoperative passage of flatus and feces to evaluate the restoration of bowel function, and visual analog scales (VAS) for pain during rest and movement. Scores were assessed at 2, 4, 8, 16, 24, 36 and 48 hr postoperatively.
Results: The experimental group had a shorter time to the first postoperative passage of flatus (51.9 ± 16.6 hr vs 87.0 ± 19.5 hr, P < 0.001) and feces (95.3 ± 25.0 hr vs 132.9 ± 29.4 hr, P < 0.001). No differences were found in either resting or active VAS between the two groups.
Conclusion: Epidural naloxone reduces epidural morphine-induced intestinal hypomotility without reversing its analgesic effects.
CO-ADMINISTRATION of epidural morphine and bupivacaine is an effective method of postoperative pain control that maintains analgesia while reducing the side effects when compared with epidural morphine alone.1 Postoperative gastric emptying is delayed after epidural analgesia with morphine compared with epidural bupivacaine2,3 and, for this reason, some surgeons are not inclined to use an epidural for postoperative pain control.
Choi et al.4 found in a recent report that epidural naloxone preserves analgesia while minimizing the side effects of itching and nausea. Animal experiments have shown that an opioid antagonist such as naloxone reverses the morphine-induced decline in intestinal motility,5 and clinical experiments have also documented that intravenous or subcutaneous injection of naloxone can antagonize opioid-related intestinal hypomotility.6,7
The effect of epidural naloxone on human intestinal hypomotility has not been studied. We hypothesized that co-administration of naloxone would preserve both analgesia and intestinal motility when epidural bupivacaine and morphine are used for pain control after gastrectomy.
| Methods |
|---|
|
|
|---|
After identification of the epidural space between the 8th and 9th thoracic vertebrae using the loss of resistance technique, a 20 gauge epidural catheter was placed three centimeters cephalad into the epidural space with patients in a left lateral decubitus position. Sensory block at least to the dermatome of the 6th thoracic vertebra in the supine position was confirmed in each case. Patients underwent anesthetic induction and tracheal intubation after 4 mgkg1 thiopental and 1 mgkg1 succinylcholine. Muscle relaxation was induced by 0.08 mgkg1 pancuronium, and general anesthesia was maintained with 3 Lmin1 N2O and 2 Lmin1 O2 using a semi-closed circle system. Controlled ventilation was conducted with a tidal volume of 10 mlkg1, I:E ratio at 1:2, and respiratory rate of 8/min ~ 12/min.
Ten minutes after induction of general anesthesia, 3 mg morphine were administered via the epidural catheter. Patients then received 5 ml bupivacaine 0.33% at one hour intervals until the end of surgery. When the surgeons closed the peritoneum, a continuous infusor (Baxter®, USA) was attached to the epidural catheter for 48 hr postoperative pain control.
Patients were randomly assigned to one of two groups by flipping a coin; naloxone was added to the continuous infusor in the treatment group, but not in the control group. The control group (n=18) received 3 mg morphine in 100 ml bupivacaine 0.125% at 2 mlhr1 for two days via the infusor. The treatment group (n=25) received the same mixture, but with the addition of 0.208 µgkg1hr1 naloxone using the same method.
We used Visual Analog Scales (VAS; 10 cm) to assess postoperative pain at 2, 4, 8, 16, 24, 36, and 48 hr, both at rest and after coughing. In order to evaluate the recovery of intestinal motility, the times to the first postoperative passage of flatus and feces were measured as well. All assessments were carried out by anesthesiologists who had not taken part in the experiment and were blinded to the group assignment.
Pain scales were analyzed to identify inter-group differences using the Mann-Whitney U test. The independent t test carried out for difference in intestinal motility times were analyzed using Student's t test for independent data.
| Results |
|---|
|
|
|---|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The VAS during coughing was 1 or 2 points higher than at rest until four hours postoperatively, but was not different thereafter. This difference probably occurs because afferent sensory transmission from the surgical wound differs during rest and movement and, as a result, a qualitatively different evaluation is made.8 Since intestinal motility has a high correlation with postoperative ambulation, it is essential to carry out an inter-group comparison of analgesia during movement as well as at rest.
Morphine and bupivacaine influence postoperative intestinal motility in different ways. Bupivacaine has been reported to relieve the postoperative ileus by blocking inhibitory spinal reflexes to the gut that are activated by abdominal surgery.2,9 Morphine, on the other hand, has either a direct action on colonic smooth muscle or a presynaptic inhibitory action at a ganglionic site in non-adrenergic inhibitory nerves.10 Its influence on intestinal motility is a result of its action on opioid receptors both at the supraspinal and spinal levels.11 The gastrointestinal effects of opioids are mediated primarily by mu receptors at the supraspinal level while both delta and mu receptors mediate this effect at the spinal level.12 Morphine inhibits the intestinal propulsion, thereby increasing transit time of the substances, although it enhances contraction of the intestine.3
However, we found differing opinions in the literature on the gastrointestinal effects of bupivacaine and morphine co-administered via the epidural catheter. While Liu et al.13 and de Leon-Casasola et al.14 reported that its combination improved pain control compared with traditional methods using intravenous opioid, Hjortsø et al.15 found little benefit in terms of intestinal motility when opioid and bupivacaine were used in combination. Epidural morphine has a negative effect on the recovery of intestinal motility.1619
We found the time to the first postoperative passage of flatus and feces after surgery was reduced in the experimental group that was given the antagonist. We believe that the use of epidural naloxone antagonized the morphine-induced intestinal hypomotility and infer from this that the intestinal hypomotility from morphine is mediated by both central and systemic receptor level,20 and that this mechanism can be prevented by epidural administration of naloxone.
As a morphine antagonist, naloxone acts directly on opioid receptors and is used to reverse clinical side-effects of opioid. However, titration of the dose is critical since it has differing effects at different doses.2123 The epidural administration of 0.208 ugkg1hr1 naloxone in our experiment was an effective and safe dose that maintained the analgesic effects of morphine and prevented one of morphine's side-effects - delayed recovery of intestinal motility.
We concluded that the intestinal hypomotility induced by epidural morphine can be reversed by epidural administration of 0.208 ugkg1hr1 naloxone without affecting its analgesic effects.
Accepted for publication September 22, 2000.
| References |
|---|
|
|
|---|
2
Wattwil M, Thorén T, Hennerdal S, Garvill JE. Epidural analgesia with bupivacaine reduces postoperative paralytic ileus after hysterectomy. Anesth Analg 1989; 68: 3538.
3 Thörn SE, Wattwil M, Näslund I. Postoperative epidural morphine, but not epidural bupivacaine, delays gastric emptying on the first day after cholecystectomy. Reg Anesth 1992; 17: 914.[Medline]
4
Choi JH, Lee J, Choi JH, Bishop MJ. Epidural naloxone reduces pruritus and nausea without affecting analgesia by epidural morphine in bupivacaine. Can J Anesth 2000; 47: 337.
5 De Winter BY, Boeckxstaens GE, De Man JG, Moreels TG, Herman AG, Pelckmans PA. Effects of mu- and kappa-opioid receptors on postoperative ileus in rats. Eur J Pharmacol 1997; 339: 637.[Medline]
6
Frame WT, Allison RH, Moir DD, Nimmo WS. Effect of naloxone on gastric emptying during labour. Br J Anaesth 1984; 56: 2636.
7 Schang JC, Devroede G. Beneficial effects of naloxone in a patient with intestinal pseudoobstruction. Am J Gastroenterol 1985; 80: 40711.[Medline]
8
Dahl JB, Rosenberg J, Hansen BL, Hjortsø NC, Kehlet H. Differential analgesic effects of low-dose epidural morphine and morphine-bupivacaine at rest and during mobilization after major abdominal surgery. Anesth Analg 1992; 74: 3625.
9 Glise H, Lindahl BO, Abrahamsson H. Reflex adrenergic inhibition of gastric motility by nociceptive intestinal stimulation and peritoneal irritation in the cat. Scand J Gastroenterol 1980; 15: 67381.[Medline]
10 Gillan MG, Pollock D. Acute effects of morphine and opioid peptides on the motility and responses of the rat colon to electrical stimulation. Br J Pharmacol 1980; 68: 38192.[Medline]
11 Porreca F, Filla A, Burks TF. Spinal cord-mediated opiate effects on gastrointestinal transit in mice. Eur J Pharmacol 1983; 86: 1356.
12
Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 1984; 230: 3418.
13 Liu SS, Carpenter RL, Mackey DC, et al. Effects of perioperative analgesic technique on rate of recovery after colon surgery. Anesthesiology 1995; 83: 75765.[Medline]
14 de Leon-Casasola OA, Karabella D, Lema MJ. Bowel function recovery after radical hysterectomies: thoracic epidural bupivacaine-morphine versus intravenous patient-controlled analgesia with morphine: a pilot study. J Clin Anesth 1996; 8: 8792.[Medline]
15 Hjortsø NC, Neumann P, Frosig F, et al. A controlled study on the effect of epidural analgesia with local anaesthetics and morphine on morbidity after abdominal surgery. Acta Anaesthesiol Scand 1985; 29: 7906.[Medline]
16
Thorén T, Wattwil M. Effects on gastric emptying of thoracic epidural analgesia with morphine or bupivacaine. Anesth Analg 1988; 67: 68794.
17 Thorén T, Tanghöj H, Wattwil M, Järnerot G. Epidural morphine delays gastric emptying and small intestinal transit in volunteers. Acta Anaesthesiol Scand 1989; 33: 17480.[Medline]
18 Thörn SE, Wattwil M, Källander A. Effects of epidural morphine and epidural bupivacaine on gastroduodenal motility during the fasted state and after food intake. Acta Anaesthesiol Scand 1994; 38: 5762.[Medline]
19 Scheinin B, Asantila R, Orko R. The effect of bupivacaine and morphine on pain and bowel function after colonic surgery. Acta Anaesthesiol Scand 1987; 31: 1614.[Medline]
20 Thorn SE, Wattwil M, Lindberg G, Sawe J. Systemic and central effects of morphine on gastroduodenal motility. Acta Anaesthesiol Scand 1996; 40: 17786.[Medline]
21
Frederickson RC, Burgis V, Edwards JD. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science 1977; 198: 7568.
22 Jacob JJ, Tremblay EC, Colombel M-C. Enhancement of nociceptive reactions by naloxone in mice and rats. (French) Psychopharmacologia 1974; 37: 21723.
23 Chesher GB, Chan B. Footshock induced analgesia in mice: its reversal by naloxone and cross tolerance with morphine. Life Sci 1977; 21: 156974.[Medline]
This article has been cited by other articles:
![]() |
M. K. Kim, S. B. Nam, M. J. Cho, and Y.-S. Shin Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia Br. J. Anaesth., August 1, 2007; 99(2): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |